ABSTRACT
Rabies still causes about 60,000 human deaths per year, mainly in poor populations in Africa and Asia. However, since Louis Pasteur developed the first vaccine 130 years ago, prophylactic measures have been considerably improved and simplified. They now consist of the vaccine combined with purified rabies immunoglobulins of equine or human origin. In general, however, post-exposure prophylaxis protocols are long and expensive. Furthermore, the immunoglobulins used for associated serotherapy are costly and not widely available in developing countries. Approaches have been developed to deal with these two issues that offer hope for a paradigm shift for the benefit of exposed populations. Finally, mass rabies vaccination in dogs, which are the most cost-effective measure for preventing rabies in humans, are difficult to implement and sometimes have moderate effectiveness. The identification and analysis of the epidemiological drivers conditioning the circulation of the virus in dog populations allow a better understanding of the key control points that need to be associated with these campaigns for a better efficacy.
ABSTRACT
INTRODUCTION: Hypermucoviscous Klebsiella pneumoniae (KP) strains are responsible for complicated bacteremia with multiple septic sites (liver, central nervous system, muscles). We aimed to compare the clinical severity of patients presenting with KP bacteremia based on the hypermucoviscous or non-hypermucoviscous characteristic of the strains. METHODS: Observational retrospective study successively including all patients with KP bacteremia from May 2013 to March 2015 at the tertiary medical center of New Caledonia. The hypermucoviscous characteristic was defined by the string test results and molecular analysis to determine the capsular serotype. RESULTS: A total of 55 bacteremic patients were included in the study; 27% of isolated strains were hypermucoviscous. Hypermucoviscous strains accounted for two-thirds of community-acquired infections (72.5% vs. 33.4%, p=0.01). The rate of intensive care hospitalization was high (hypermucoviscous 46.7%; standard 52.5%) without any difference between the two groups. No significant difference was observed in case fatality (hypermucoviscous 46.7% vs. standard 15%, p=0.07) but patients with hypermucoviscous strains had longer hospital stays (73.5 days versus 50.7 days, p=0.04) and longer persistence of positive blood cultures despite an appropriate treatment (OR 1.41, 95% CI: 1.0-1.96, p=0.045). CONCLUSION: Hypermucoviscous KP bacteremia account for most community-acquired Klebsiella infections in New Caledonia and are associated with longer hospital stay and persistence of positive blood cultures despite the implementation of an appropriate treatment.
Subject(s)
Bacteremia/microbiology , Klebsiella Infections/microbiology , Klebsiella pneumoniae/classification , Klebsiella pneumoniae/pathogenicity , Adult , Aged , Female , Humans , Male , Middle Aged , Retrospective Studies , Severity of Illness IndexABSTRACT
A live intraocular nematode was identified from a 37 year-old man presented with iritis, pain, redness, lacrimation, swelling, vision loss and intermittent blindness during many hours per day of the left eye. By using slit lamp examination, a worm was removed from iris in an ophthalmology outpatient department setting and sent to the Medical Microbiology Laboratory, Institut Pasteur du Cambodge. Gnathostoma spinigerum was identified, based on its typical morphology via microscopic examination. Based on our diagnosis, the patient was treated by oral albendazole and responded well to this therapy.
Subject(s)
Eye Infections, Parasitic/epidemiology , Gnathostomiasis/epidemiology , Iritis/epidemiology , Adult , Agricultural Workers' Diseases/drug therapy , Agricultural Workers' Diseases/parasitology , Albendazole/therapeutic use , Animals , Anthelmintics/therapeutic use , Cambodia/epidemiology , Eye Infections, Parasitic/drug therapy , Eye Infections, Parasitic/parasitology , Gnathostoma/growth & development , Gnathostoma/isolation & purification , Gnathostoma/ultrastructure , Gnathostomiasis/drug therapy , Humans , Iris/parasitology , Iritis/drug therapy , Iritis/parasitology , Larva , Male , Paracentesis , Vision Disorders/etiology , Vision Disorders/parasitologyABSTRACT
In February 2011, a mother and her child from Banteay Meanchey Province, Cambodia, were diagnosed, postmortem, with avian influenza A(H5N1) virus infection. A field investigation was conducted by teams from the Cambodian Ministry of Health, the World Health Organization and the Institut Pasteur in Cambodia. Nasopharyngeal, throat and serum specimens collected from 11 household or three neighbour contacts including two suspect cases tested negative by reverse transcriptase-polymerase chain reaction (RT-PCR) for A(H5N1). Follow-up sera from the 11 household contacts also tested negative for A(H5N1) antibodies. Twenty-six HCW who were exposed to the cases without taking adequate personal protective measures self-monitored and none developed symptoms within the two following weeks. An unknown number of passengers travelling with the cases on a minibus while they were symptomatic could not be traced but no clusters of severe respiratory illnesses were detected through the Cambodian surveillance systems in the two weeks after that. The likely cause of the fatal infection in the mother and the child was common-source exposure in Preah Sdach District, Prey Veng Province. Human-to-human transmission of A(H5N1) virus was unlikely but genetic susceptibility is suspected. Clusters of A(H5N1) virus infection should be systematically investigated to rule out any human-to-human transmission.
Subject(s)
Influenza A Virus, H5N1 Subtype/isolation & purification , Influenza in Birds/transmission , Influenza, Human/transmission , Animals , Autopsy , Birds , Cambodia , Contact Tracing , Fatal Outcome , Female , Humans , Infant , Influenza in Birds/virology , Influenza, Human/pathology , Influenza, Human/virology , Male , Reverse Transcriptase Polymerase Chain Reaction , Sentinel Surveillance , Young AdultABSTRACT
From January to September 2013, a marked increase in notifications of Salmonella Paratyphi A infections among travellers returning from Cambodia occurred in France. An investigation revealed 35 cases without a common source: 21 in France, five in Germany, three in the Netherlands, one in Norway, one in the United Kingdom, four in New-Zealand. Data suggest an ongoing event that should trigger further investigation. Travellers to Cambodia should observe preventive measures including good personal hygiene and food handling practices.
Subject(s)
Disease Notification/statistics & numerical data , Paratyphoid Fever/diagnosis , Paratyphoid Fever/epidemiology , Salmonella paratyphi A/isolation & purification , Travel , Adolescent , Adult , Aged , Cambodia , Child , Child, Preschool , Female , France/epidemiology , Humans , Incidence , Male , Middle Aged , Paratyphoid Fever/transmission , Population Surveillance , Young AdultABSTRACT
Malaria, which was eliminated first from Metropolitan France (mainland and Corsica), then in the French West Indies and the Reunion Island during the 20(th) century, remains endemic in two French territories: French Guiana and the Indian Ocean Mayotte island. Despite differences in the dominating plasmodial species and epidemiological patterns, these two territories have achieved marked quantitative improvements (in the reported number of cases and severe cases) thanks to efforts undertaken over the past decade. The situation, however, remains a concern from a qualitative standpoint with the emergence of resistance to antimalarial drugs and logistical and administrative issues which hinder access to treatment. Although malaria was eradicated in Metropolitan France half a century ago, competent vectors remain present in part or all of these territories and can give rise to limited outbreaks.
Subject(s)
Malaria/epidemiology , Africa , Animals , Anopheles/parasitology , Antimalarials/therapeutic use , Comoros/epidemiology , Emigration and Immigration , Endemic Diseases , Female , France/epidemiology , French Guiana/epidemiology , Humans , Incidence , Insect Bites and Stings/parasitology , Insect Vectors/parasitology , Insecticide-Treated Bednets , Malaria/drug therapy , Malaria/prevention & control , Malaria/transmission , Male , Mosquito Control , Pregnancy , Pregnancy Complications, Parasitic/epidemiology , Pregnancy Complications, Parasitic/prevention & control , Reunion/epidemiology , Travel , West Indies/epidemiologyABSTRACT
Since November 2003, the epidemic intelligence team at the French Institut de Veille Sanitaire has been gathering data on influenza A(H5N1) circulation in poultry and on human cases worldwide. As Indonesia notifies the world's 500th case to the World Health Organization, we discuss the epidemiological situation and trends of A(H5N1) influenza. Although the overall number of cases reported worldwide has decreased, influenza A(H5N1) continues to circulate intensely in some countries and more cases are to be expected, especially in Egypt and Indonesia.
Subject(s)
Disease Outbreaks , Global Health , Influenza A Virus, H5N1 Subtype/isolation & purification , Influenza, Human/epidemiology , History, 21st Century , Humans , Influenza, Human/history , Influenza, Human/mortality , Influenza, Human/transmission , Population SurveillanceABSTRACT
There are few structured data available to assess the risks associated with pandemic influenza A(H1N1)v infection according to ethnic groups. In countries of the Americas and the Pacific where these data are available, the attack rates are higher in indigenous populations, who also appear to be at approximately three to six-fold higher risk of developing severe disease and of dying. These observations may be associated with documented risk factors for severe disease and death associated with pandemic H1N1 influenza infection (especially the generally higher prevalence of diabetes, obesity, asthma, chronic obstructive pulmonary disease and pregnancy in indigenous populations). More speculative factors include those associated with the risk of infection (e.g. family size, crowding and poverty), differences in access to health services and, perhaps, genetic factors. Whatever the causes, this increased vulnerability of indigenous populations justify specific immediate actions in the control of the current pandemic including primary prevention (intensified hygiene promotion, chemoprophylaxis and vaccination) and secondary prevention (improved access to services and early treatment following symptoms onset) of severe pandemic H1N1 influenza infection.
Subject(s)
Disease Outbreaks , Influenza A Virus, H1N1 Subtype , Influenza, Human/epidemiology , Adolescent , Adult , Brazil/epidemiology , Humans , Indians, North American , Indians, South American , Middle Aged , Native Hawaiian or Other Pacific Islander , North America/epidemiology , Oceania/epidemiology , Young AdultABSTRACT
This article describes the characteristics of 574 deaths associated with pandemic H1N1 influenza up to 16 July 2009. Data (except from Canada and Australia) suggest that the elderly may to some extent be protected from infection. There was underlying disease in at least half of the fatal cases. Two risk factors seem of particular importance: pregnancy and metabolic condition (including obesity which has not been considered as risk factor in previous pandemics or seasonal influenza).
Subject(s)
Disease Outbreaks/statistics & numerical data , Influenza A Virus, H1N1 Subtype , Influenza, Human/epidemiology , Adult , Age Distribution , Aged , Child , Female , Humans , Incidence , Internationality , Pregnancy , Risk Assessment , Risk Factors , Sex Distribution , Survival Analysis , Survival RateABSTRACT
Plague is circulating regularly in localised areas worldwide, causing sporadic cases outside Africa and remains endemic or causes limited outbreaks in some African countries. Furthermore, some notable outbreaks have been reported in Asia in the last 20 years. A limited outbreak with five cases has recently been notified by the health authorities of the Libyan Arab Jamahiriya.
Subject(s)
Arabs/statistics & numerical data , Disease Outbreaks/statistics & numerical data , Plague/epidemiology , Humans , Incidence , Libya/epidemiology , Population Surveillance , Risk Assessment/methods , Risk FactorsABSTRACT
INTRODUCTION: Dengue fever is the main emerging vector-borne disease worldwide. It was estimated that 40% of the world population is at risk. A potential vector (Aedes albopictus) is present in four French departments of the southeast area of metropolitan France. METHOD: The authors tried to document the number of imported cases of dengue diagnosed from 2001 to 2006, inclusive, as well as their main features. RESULTS: Between 12 and 28 cases of imported dengue were diagnosed every month during that period (eight to 18 cases per month except for years 2001-2002 during which an important dengue epidemic was documented in the French West Indies). Nearly 40% of the cases were imported between June and September during which the vector is active in the metropolitan area. CONCLUSION: This data underlines the strong and close link between the endemic zones of the French territory (French West Indies and Guyana) and the risk of imported cases to metropolitan France. The identification of this "importation track" entails strengthening the system for detecting and managing imported dengue cases in metropolitan France when a dengue epidemic is detected in the French West Indies.
Subject(s)
Dengue/epidemiology , Travel , Aedes , Africa , Animals , Asia, Southeastern , France/epidemiology , Humans , India , Madagascar , Seasons , South America , Sri Lanka , Urban PopulationABSTRACT
An estimation of the number of Trypanosoma cruzi infected individuals and expected number of Chagasic cardiomyopathies in France (excluding French Guyana) was conducted in June, 2009 by InVS. Different risk groups were identified: Latino-Americans (LA) from endemic area (naturalized, legal and illegal migrants, adopted children), children born from LA's mother, French Guyanese living in Metropolitan France, expatriated and travellers from endemic countries. Prevalence rates by country of origin were applied to official data on risk populations obtained from the International Adoption Agency, Tourism Direction and French ministries (Finances, Foreign Affairs and Migrations). Around 157,000 individuals were potentially exposed. It is estimated than 1,464 [895-2,619] are infected by T. cruzi, of which 63 to 555 may evolve towards a chronic cardiomyopathy. This figure is within the range of earlier estimations of InVS and Guerri-Guttenberg. Taking into account illegal immigrants, the expected number of infected individuals in France should increase greatly this estimation.
Subject(s)
Chagas Disease/complications , Chagas Disease/epidemiology , Heart Diseases/parasitology , Adoption , Child , Emigration and Immigration/statistics & numerical data , France/epidemiology , French Guiana/epidemiology , Heart Diseases/epidemiology , Humans , Latin America/ethnology , Prevalence , Risk Factors , Urban Population/statistics & numerical dataABSTRACT
The epidemiology of several viral diseases underwent profound changes in South-East Asia and Oceania over the past decades. This was due to several factors, including the geographical distribution of vectors and the viruses they transmit; increasing traveling and trade; increasing ecological and demographic pressure. We reviewed the current state of knowledge based on published sources and available epidemiological data. The review was limited to potentially emerging viruses in Southeast Asia and the Pacific reported in human cases. Dengue, Chikungunya, and Japanese Encephalitis viruses have recurred on a yearly basis with a steady increase in these regions. Ross River and Barmah viruses now appear regularly in Australia, in an increasing number of cases. Nipah virus strikes regularly with limited but deadly epidemics in Southeast Asia. Finally, infections by lyssaviruses, Kunjin, Murray Valley, or Zika viruses were also reviewed.
Subject(s)
Communicable Diseases, Emerging/epidemiology , Virus Diseases/epidemiology , Alphavirus Infections/epidemiology , Asia, Southeastern/epidemiology , Communicable Diseases, Emerging/virology , Flaviviridae Infections/epidemiology , Henipavirus Infections/epidemiology , Humans , Oceania , Reoviridae Infections/epidemiology , Rhabdoviridae Infections/epidemiologySubject(s)
Cholera/drug therapy , Cholera/epidemiology , Disease Outbreaks/statistics & numerical data , Drug Resistance, Bacterial , Risk Assessment/methods , Travel , Vibrio cholerae/drug effects , France/epidemiology , Humans , Incidence , India/epidemiology , Population Surveillance , Risk FactorsABSTRACT
OBJECTIVES: To evaluate safety-engineered devices (SEDs) with respect to their effectiveness in preventing needlestick injuries (NSIs) in healthcare settings and their importance among other preventive measures. DESIGN: Multicenter prospective survey with a 1-year follow-up period during which all incident NSIs and their circumstances were reported. Data were prospectively collected during a 12-month period from April 1999 through March 2000. The procedures for which the risk of NSI was high were also reported 1 week per quarter to estimate procedure-specific NSI rates. Device types were documented. Because SEDs were not in use when a similar survey was conducted in 1990, their impact was also evaluated by comparing findings from the recent and previous surveys. SETTING: A total of 102 medical units from 32 hospitals in France. PARTICIPANTS: A total of 1,506 nurses in medical or intensive care units. RESULTS: A total of 110 NSIs occurring during at-risk procedures performed by nurses were documented. According to data from the 2000 survey, use of SEDs during phlebotomy procedures was associated with a 74% lower risk (P<.01). The mean NSI rate for all relevant nursing procedures was estimated to be 4.72 cases per 100,000 procedures, for a 75% decrease since 1990 (P<.01); however, the decrease in NSI rates varied considerably according to procedure type. Between 1990 and 2000, decreases in the NSI rates for each procedure were strongly correlated with increases in the frequency of SED use (r=0.88; P<.02). CONCLUSION: In this French hospital network, the use of SEDs was associated with a significantly lower NSI rate and was probably the most important preventive factor.
Subject(s)
Hospitals , Needlestick Injuries/epidemiology , Needlestick Injuries/prevention & control , Nursing Staff, Hospital , Protective Devices/statistics & numerical data , Biomedical Engineering , Equipment Design , France/epidemiology , Hospitals/statistics & numerical data , Humans , Incidence , Intensive Care Units , Nursing Staff, Hospital/statistics & numerical data , Occupational Health , Risk Management , Surveys and QuestionnairesABSTRACT
BACKGROUND: Factors that influence the risk for HCV infection after occupational exposure to hepatitis C virus (HCV) have not yet been determined. The objective of this study was to assess potential risk factors for Hepatitis C seroconversion after occupational exposure to HCV. METHODS: We conducted a European matched case-control study from 01/01/1991 through 31/12/ 2002. Cases were Health Care Workers (HCWs) who were HCV seronegative at the time of exposure, sustained a documented exposure to HCV, and present documented HCV seroconversion temporally associated with the exposure. Controls-HCWs had a documented exposure to HCV, were HCV seronegative at the time of exposure, and remained so at least 6 months later. Controls were matched to cases for the center and the time period of the exposure occurrence. RESULTS: 60 cases and 204 controls were included. All cases were exposed to HCV-infected materials through percutaneous injuries. Those for whom information was available (61.6%) were exposed to viremic source patients. Multivariate conditional logistic regression analysis, in which HCV viral load was not introduced because of missing values, identified needle placed in the source patient's vein or artery (Odds Ratio [OR]=100.1; 95% Confidence Interval [CI]=7.3-1365.7), deep injury (OR=155.2; 95%CI=7.1-3417.2), and HCW's gender (M vs. F: OR=3.1; 95%CI=1.0-10.0) as risk factors for HCV infection. In univariate unmatched analysis the risk of HCV transmission was increased 11-fold (C195%=1.1-114.1) in HCWs exposed to sources with a viral load>6 log10 copies/mL when compared to sources with a HCV viral load<4 log10 copies/mL. CONCLUSION: The risk of HCV transmission after percutaneous exposure increases with a larger volume of blood, and, a higher titer of HCV in the source patient's blood. The role of HCW's gender need to be further investigated. The results of this study have important implications for counselling and follow-up of HCWs after exposure.
Subject(s)
Health Personnel , Hepatitis C/transmission , Infectious Disease Transmission, Patient-to-Professional , Occupational Exposure , Adult , Case-Control Studies , Confidence Intervals , Data Interpretation, Statistical , Europe , Female , Hepacivirus/genetics , Hepacivirus/isolation & purification , Hepatitis C/immunology , Hepatitis C/virology , Hepatitis C Antibodies/analysis , Humans , Male , Middle Aged , Odds Ratio , RNA, Viral/analysis , Risk Factors , Surveys and Questionnaires , Time Factors , Viral LoadSubject(s)
Alphavirus Infections/epidemiology , Chikungunya virus , Travel , Urban Population/statistics & numerical data , Adolescent , Adult , Aedes/virology , Aged , Aged, 80 and over , Alphavirus Infections/transmission , Animals , Child , Child, Preschool , Demography , Female , France/epidemiology , Humans , Infant , Male , Middle Aged , Reunion/epidemiology , Sentinel SurveillanceABSTRACT
Cholera is a bacterial infection, which causes digestive symptoms and massive diarrhoea. It may lead to dehydration and death if appropriate medical management is not rapidly initiated. Most cases of infection by choleric vibrio, however, remain symptom-free or may mimic common gastroenteritis. A review of two cases of imported cholera in France in the summer of 2005 and the community- and hospital-based investigation, which they triggered, enabled the incident management teams to assess risks of transmission. There were no secondary cases among 58 hospital contacts and 15 family contacts of the cases. Clinicians will find a discussion of possible clinical presentations and the risk of secondary transmission, in the context of progressing epidemics in countries, which have maintained close ties with France.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Cholera/drug therapy , Humans , Infant , Male , Treatment Outcome , Vibrio cholerae/growth & development , Vibrio cholerae/isolation & purificationABSTRACT
Injection pens are used by patients when auto-administering medication (insulin, interferon, apokinon etc.) by the subcutaneous route. The objective of this study was to evaluate the rate of injection pen use by healthcare workers (HCWs) and the associated risk of needlestick injuries to document and compare injury rates between injection pens and subcutaneous syringes. A one-year retrospective study was conducted in 24 sentinel French public hospitals. All needlestick injuries linked to subcutaneous injection procedures, which were voluntarily reported to occupational medicine departments by HCWs between October 1999 and September 2000, were documented using a standardized questionnaire. Additional data (total number of needlestick injuries reported, number of subcutaneous injection devices purchased) were collected over the same period. A total of 144 needlestick injuries associated with subcutaneous injection were reported. The needlestick injury rate for injection pens was six times the rate for disposable syringes. Needlestick injuries with injection pens accounted for 39% of needlestick injuries linked with subcutaneous injection. In all, 60% of needlestick injuries with injection pens were related to disassembly. Injection pens are associated with needlestick injuries six times more often than syringes. Nevertheless, injection pens have been shown to improve the quality of treatment for patients and may improve treatment observance. This study points to the need for safety-engineered injection pens.